Symposium: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (BM)

Moderator(s)

• 

  Weiwei Tan, PhD

  Senior Director
  Pfizer Inc
  San Diego, California

Presentations:

• 9:00 AM – 9:30 AM ET

  Tackle the Conundrums of Anti-Tumor Antibody Drug Development with PK/PD Modeling
  

  Speaker: Jun Wang, PhD – Boehringer Ingelheim Corporation
• 9:30 AM – 10:00 AM ET

  Overcoming Pitfalls During the Development of mRNA Therapies From Bench to Bedside
  

  Speaker: Oleg Milberg, PhD – Moderna, Inc.
• 10:00 AM – 10:30 AM ET

  ADME Approaches for the Pfizer Oral COVID-19 Protease Inhibitor Program
  

  Speaker: Amit Kalgutkar, PhD – Pfizer
• 10:30 AM – 11:00 AM ET

  Challenges and Opportunities with Preclinical to Clinical Translation of CAR-T Cell Therapy
  

  Speaker: Aman P. Singh, M.S., PhD – Takeda Pharmaceuticals, USA